End-to-end Cell Therapy CDMO Solutions
As a CDMO Partner for Life™ our goal is to advance your cell therapies from lab to commercial scale leveraging our CGT expertise and global cGMP network. As a patient-driven organization delivering the highest quality cell therapy manufacturing solutions is our priority.
ADVANCE YOUR CELL THERAPIES WITH US
OUR AUTOLOGOUS & ALLOGENEIC CELL THERAPY SERVICES
Types of Cells We Support
Cell Derived Therapies − CTL, CAR, TCR, NK and Tissue-Derived Therapies − Mesenchymal Stem Cell, Hematopoietic Stem Cells, Induced Pluripotent Stem Cells.
Clinical and Commercial Manufacturing
Expansive cGMP manufacturing space complete with advanced technologies and electronic batch records to support clinical and commercial production goals at the highest quality.
Supply Chain and Logistics
Experience-driven strategies and processes that enable program readiness and execution of manufacturing, disposition, and distribution activities. This includes materials supply, assembly, labeling and packaging and cryogenic storage.
Quality and Compliance
Superior program management, Quality Management System and Quality Control programs designed to ensure product quality meets US and EU regulatory standards, with flexibility to enable clinical and commercial programs.
Process Development and Optimization
Highly experienced teams support development and optimization of world class cell therapy processes that meet the needs of our clients, their regulatory phase, and their goals.
Analytical Development and Testing
Our scientists can develop, optimize, and validate analytical methods to support client-specific assays – including safety and efficacy assays to enable successful transfer to our QC labs.
Tech Transfer / NPI (MSAT)
The depth and breadth of FDB’s Manufacturing, Science & Technology program ensures seamless transfer of knowledge from our customers into the capable hands of our cGMP manufacturing teams.
OUR GLOBAL CGT NETWORK
Our global cell and gene therapy network includes 2 primary production sites and 3 development sites throughout the US and Europe. Our Thousand Oaks, California location is a purpose built, dedicated cell therapy facility for clinical and commercial production. Our Texas facility can address viral vector needs for cell therapies, has produced induced Pluripotent Stem Cells, and has abundant production space to meet scale up goals for our late phase stem cell therapy customers. Support for cell therapy process and analytical development are possible in our Watertown, MA, USA and Darlington, UK sites, and at our Billingham, UK site in 2025.
FACILITY SPOTLIGHTS
Thousand Oaks, California, USA
- Active as an Allogeneic T-Cell manufacturing site since 2018
- 170+ Skilled Employees
- Established Clinical and Commercial Cell Therapy Manufacturing
- 90,000 sq. ft. Expandible and Flexible
- Access to Multiple Regional and International Airports
College Station,Texas, USA
- Advanced Therapies: Viral Vectors & Various Cell Lines
- 800+ Skilled Employees
- cGMP Drug Product – Viral Products
- cGMP Drug Product – Recombinant Proteins
- 10,000 sq.ft. cGMP Production Space
- Access to Multiple Regional and International Airports
Partnerships
FUJIFILM Diosynth Biotechnologies and RoosterBio announce collaboration to enable cGMP Manufacturing of Cell and Exosome Therapies – read our press release.
Interested in Cell Therapy Manufacturing Services?
We offer industry-leading Cell Therapy CDMO services. Contact us to speak with our experts today.